98%
921
2 minutes
20
This study investigates the correlation between hyperuricemia and the development of in-stent restenosis (ISR) following percutaneous coronary intervention (PCI) in patients with unstable angina. We analyzed clinical data from 128 patients diagnosed with unstable angina who underwent PCI. Patients were categorized into 2 groups: hyperuricemia group (34 cases) and non-hyperuricemia group (94 cases), based on the presence or absence of hyperuricemia. A multivariate Cox regression model was used to determine the correlation between hyperuricemia and the development of ISR. The proportion of patients who developed ISR following PCI was significantly higher in the hyperuricemia group (26.5%) than in the non-hyperuricemia group (13.8%) (P = .008). The results of the multivariate Cox regression model indicated that hyperuricemia was an independent predictor for the development of ISR following PCI (hazard ratio = 6.299, 95% confidence interval: 1.955-20.298, P = .002). Hyperuricemia was still substantially correlated with ISR after correction for confounders in patients with standard quantitative flow ratios following PCI (>0.89) (hazard ratio = 5.226, 95% confidence interval: 1.497-18.243, P = .010). Patients with hyperuricemia have a significantly increased risk of ISR following PCI. Patients who have undergone PCI therapy should be screened for hyperuricemia, closely monitored, and given aggressive uric acid-lowering therapy when necessary.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366974 | PMC |
http://dx.doi.org/10.1097/MD.0000000000043408 | DOI Listing |
Turk J Pediatr
September 2025
West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Background: The α-actinin-4 (ACTN4) gene encodes an actin-binding protein, which plays a crucial role in maintaining the structure and function of podocytes. Previous studies have confirmed that ACTN4 mutations can lead to focal segmental glomerulosclerosis-1 (FSGS1), a rare disease primarily manifesting in adolescence or adulthood, characterized by mild to moderate proteinuria, with some cases progressing slowly to end-stage renal disease.
Case Presentation: We report a 12.
Medicine (Baltimore)
September 2025
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Serum uric acid (SUA) levels are linked to increased disease vulnerability and higher recurrence rates; however, the exact causal relationships are elusive. Despite the prevalent hyperuricemia in East Asian populations, comprehensive research on the intricate association between SUA levels and disease is lacking. To address this, a study utilizing a 2-sample Mendelian randomization (MR) approach was conducted in East Asian populations.
View Article and Find Full Text PDFRen Fail
December 2025
Department of Nephrology, The First Hospital of Jilin University, Changchun, China.
Background: Inflammation and hyperuricemia are closely associated with chronic kidney disease (CKD). The systemic inflammation response index (SIRI), systemic immune-inflammation index (SII), monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) are emerging as novel biomarkers. While, the synergistic effects of these biomarkers with hyperuricemia on CKD remain unclear.
View Article and Find Full Text PDFInt Immunopharmacol
September 2025
Transplantation Center, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China; Key Laboratory of Translational Research in Transplantation Medicine of National Health Commission, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China; Clinical Resea
Kidney transplantation (KT) is an effective treatment for end-stage renal disease, with over 90 % of recipients requiring lifelong tacrolimus (Tac). However, The Tac pharmacokinetics exhibit high intra-patient variability (IPV), posing significant challenges. This study included 102 KT recipients at our center from October 2022 to December 2023.
View Article and Find Full Text PDFHypertension
September 2025
Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa. (L.V.D., A.Z., R.B., C.A.K., O.K., V.L., M.L., A. Shapiro, V.P., T.R., A. Staruschenko).
Background: Asymptomatic hyperuricemia is associated with poor outcomes in kidney and cardiovascular diseases, but its causative role remains controversial. Clinical studies have shown a positive correlation between increased dietary sodium intake and urinary uric acid excretion, suggesting that hyperuricemia may influence salt-sensitive hypertension and associated kidney damage.
Methods: To study the effects of mild hyperuricemia on salt-sensitive hypertension, male and female Dahl SS rats were fed a diet containing a uricase inhibitor (2% oxonic acid) and 4% NaCl (high salt) or a high salt-only diet for 3 weeks.